Virtual Reality Application During High Flow Nasal Oxygen Therapy in Children Effect on Anxiety Levels

Launched by USKUDAR UNIVERSITY · Mar 14, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at how using virtual reality (VR) goggles during high-flow nasal oxygen therapy can help reduce anxiety in children aged 6 to 12 who are in the pediatric intensive care unit. The main goal is to see if the fun and immersive experience of VR can make these children feel less anxious while they receive treatment for respiratory distress.

To be eligible for the study, children must be between 6 and 12 years old, currently receiving high-flow nasal oxygen therapy, and be able to communicate verbally. They should not have any visual or hearing problems, be in pain, or have serious medical conditions. Parents will need to provide written and verbal consent for their child to participate. If selected, children will wear VR goggles during their therapy sessions, which may help distract them and ease their anxiety about the treatment. It's important to note that the trial is not yet recruiting participants, so it may take some time before it starts.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • The child is between 6-12 years old
• • The child is receiving high flow nasal cannula oxygen therapy in the paediatric intensive care unit
• • The child has no visual and hearing problems
• • No pain according to the Wong-Baker pain scale
• • No genetic, congenital, chronic or metabolic disease
• • Being conscious and able to communicate verbally
• • Written and verbal acceptance of the child and his/her parents to participate in the study after the information.
• Exclusion Criteria:
• • The child is in pain.
• • The child is taking a sedative medication
• • The child has a fever above 37°C
• • The child presented with a severe asthma attack
• • The child's saturation value was below 92% at the time of admission